First Trust Health Care AlphaDEX (FXH) is an exchange-traded fund trading on the AMEX that provides exposure to the U.S. healthcare sector through a rules-based selection methodology. The AlphaDEX approach uses quantitative screening to identify stocks based on growth and value factors, then weights them to potentially enhance returns compared to traditional market-cap weighting. This strategy aims to overweight stocks that rank favorably on metrics like price appreciation, sales growth, and book value while underweighting or excluding weaker performers within the healthcare universe.
At $116.62, FXH sits near the upper end of its 52-week range of $97.52 to $120.34, suggesting the fund has recovered strongly from its annual lows and trades within about 3% of its recent peak. The essentially flat 24-hour change of negative 0.04% reflects typical day-to-day price movement. Traders watching FXH might focus on whether it can break through to new highs or faces resistance at current levels, as well as monitoring broader healthcare sector trends including regulatory developments, pharmaceutical pricing debates, and biotech innovation cycles that influence underlying holdings.
Information about FXH is provided for educational purposes only. Stock trading carries risk of loss. Full disclaimer.